QID 379260

Date Published: 2024-02-09

QID 379260: Zabbix Agent 2 Smartctl Plugin Code Injection Vulnerability (ZBX-23858)

Zabbix agent 2 is a new generation of Zabbix agent and may be used in place of Zabbix agent. Zabbix agent 2 has been developed to: reduce the number of TCP connections, provide improved concurrency of checks, be easily extendible with plugins.
The Zabbix Agent 2 item key smart.disk.get does not sanitize its parameters before passing them to a shell command resulting possible vulnerability for remote code execution.
Affected Versions:
Zabbix Agent 2:5.0.0 - 5.0.38
Zabbix Agent 2:6.0.0 - 6.0.23
Zabbix Agent 2:6.4.0 - 6.4.8
Zabbix Agent 2:7.0.0alpha1 - 7.0.0alpha7

QID Detection Logic (Authenticated):
The detection posts vulnerable if the installed package version is installed or not via registry keys.

An attacker can execute arbitrary code on any device having an Zabbix Agent2 listening and having smartctl installed.

CVSS V3 rated as Critical - 9.8 severity.

CVSS V2 rated as High - 7.5 severity.

Solution

To remediate this vulnerability, apply the updates listed in the 'Fixed Version' section to appropriate products.
Workaround:

Fatal error: Call to undefined function set_session() in /home/web/vulnoffice.intranet.qualys.com/en/internal/newoffice/main/get_securityfocus_workarounds.php on line 6

Vendor References

Zabbix Advisory - support.zabbix.com/browse/ZBX-23858

CVEs related to QID 379260

CVE-2023-32728 |

Software Advisories

Advisory ID	Software	Component	Link
ZBX-23858			support.zabbix.com/browse/ZBX-23858

By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].